MLICM
FLNA

Metropolitan Life Insurance Company (MetLife)’s Filana Therapeutics FLNA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,277
Closed -$46.2K – 1729
2024
Q1 		$46.2K Hold
2,277
– – ﹤0.01% 1444
2023
Q4 		$51.3K Sell
2,277
-253
-10% -$5.34K ﹤0.01% 1436
2023
Q3 		$42.1K Buy
2,530
+377
+18% +$7.47K ﹤0.01% 1504
2023
Q2 		$52.8K Hold
2,153
– – ﹤0.01% 1388
2023
Q1 		$51.9K Sell
2,153
-220
-9% -$6.09K ﹤0.01% 1368
2022
Q4 		$70.1K Hold
2,373
– – ﹤0.01% 1265
2022
Q3 		$99.2K Hold
2,373
– – ﹤0.01% 1021
2022
Q2 		$66.7K Hold
2,373
– – ﹤0.01% 1315
2022
Q1 		$88.1K Sell
2,373
-8,411
-78% -$356K ﹤0.01% 1274
2021
Q4 		$471K Hold
10,784
– – 0.01% 1475
2021
Q3 		$669K Buy
10,784
+248
+2% +$20.7K 0.01% 1251
2021
Q2 		$900K Buy
10,536
+1,414
+16% +$75.7K 0.01% 1095
2021
Q1 		$410K Sell
9,122
-1,985
-18% -$78.1K 0.01% 1535
2020
Q4 		$75.8K Buy
+11,107
New +$99.2K ﹤0.01% 2438
2014
Q3 		– Sell
-4,489
Closed -$181K – 2716
2014
Q2 		$181K Buy
+4,489
New +$166K ﹤0.01% 2576

Other funds holding FLNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s FLNA Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Filana Therapeutics (FLNA) in Q2 2024, closing a stake of 2,277 shares — an estimated $46.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in FLNA in Q2 2014 and held it in 15 quarters. The position peaked at $900K in Q2 2021. 145 funds tracked by Wall St. Rank hold FLNA as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Filana Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,277 Filana Therapeutics shares in Q2 2024, an estimated $46.2K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Filana Therapeutics in Q2 2014 and held it in 15 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Filana Therapeutics position peaked at $900K in Q2 2021.
  • 145 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.